Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (258) clinical trials

A research study is evaluating an investigational medication for evidence of early stage Alzheimer’s disease (AD).

Phase N/A

This Phase III study is designed as a randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The study will evaluate safety and tolerability, efficacy as measured by CDR-SB, and will determine if the combination therapy ALZT-OP1 will slow down, arrests, or reverse cognitive and functional decline in ...

Phase

This is a study that will include subjects with mild cognitive impairment and early Alzheimer's disease. Eligible subjects will received the investigational medication or placebo monthly through an IV infusion for 18 months and will then be able to go into a 2 year open label study where all subjects ...

Phase

This Phase III study is designed as a randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The study will evaluate safety and tolerability, efficacy as measured by CDR-SB, and will determine if the combination therapy ALZT-OP1 will slow down, arrests, or reverse cognitive and functional decline in ...

Phase

Alzheimer’s disease (AD) is the most common cause of dementia. The deposition of extracellular amyloid plaques in the brain is a hallmark pathological finding in AD. These amyloid plaques are primarily composed of Aβ peptides. This study is to evaluate crenezumab, a monoclonal antibody, that has been shown to inhibit ...

Phase

Are you caring for someone with Alzheimer's disease? If so, we need your help! We need individuals 50 years of age or older to participate in an Alzheimer’s disease research study. Eligible participants will receive study-related care, monitoring and investigational medication or placebo. For more information, please call Meridien Research ...

Phase N/A

An evaluation of an imaging agent used in PET scans to detect changes in the brain that occur in individuals with Alzheimer's disease compared to healthy volunteers.

Phase N/A

An exploratory, paired biomarker study in subjects with Alzheimer's disease vs. healthy subjects

Phase N/A